Is Quantum King EA legit?

Unknown. EALegit has not audited Quantum King EA. A listing is not a verdict that it is legit.

Has EALegit independently reviewed Quantum King EA?

Not yet. Listing is seller materials. The owner can submit source from For developers.

Does Quantum King EA use grid or martingale?

Seller materials mention grid and martingale. Not audited — we have not confirmed the code.

Can I trust the seller backtest?

No usable seller baseline is published and we have no lab replay. Treat the seller backtest as untested marketing.

Risk-flagged seller

Seller warning

EALegit review: this seller's published results hide losing days (hard-coded stop dates found in Quantum Queen X source).

Source: EALegit review

Seller price $599.99

Curve replay

Backtest vs lab reality

Zero corroboration

Seller marketing curve (claimed)Lab replay not run

Execution engine locked

Real-tick replay has not run for this listing.

Claimed profit factor

— (marketing)

Real-tick PF

Pending

Seller price: $599.99

Submit source if you own this EA View on MQL5 ↗

Quantum King EA3.1

Developed byBogdan Ion Puscasu10 EAs on record · MQL5 rating 4.92

View on MQL5 ↗

Risk flaggedGridMartingaleAUDCADM5MetaTrader 5

Seller claims

grid yes · martingale yes · SL no

EALegit summary — unaudited listing

Quantum King EA is a fully automated MetaTrader 5 expert advisor for the AUDCAD pair on the M5 timeframe. It combines a grid strategy with adaptive martingale recovery logic, dynamically adjusting grid spacing to volatility. The seller recommends low-spread ECN accounts, 1:100 leverage, a minimum deposit of $300, and a hedging account type. No stop-loss mechanism is mentioned in the description.

Lab results

Canonical test windows — a slot shows a report only after the run finishes and passes checks.
2024.01.01 → 2026.09.01	not scheduled
2024.01.01 → 2025.01.01	not scheduled
2025.03.01 → 2025.07.01	not scheduled
2026.01.01 → 2026.07.01	not scheduled

Seller evidence vs lab result

No usable seller backtest on file. The seller listing does not publish a testable baseline (dates, settings and metrics together), so reproduction is blocked — not failed. Lab results above stand on their own.

Seller evidence is transcribed from dated sources and reviewed before publication. It never changes the performance score or the audit verdict.